Disseminated on behalf of Mydecine Innovations Group Inc., may include paid advertisements. Investment Considerations Mydecine’s portfolio includes a robust line of NCEs (New Chemical Entities) and medicines based on compounds found in psychedelics, including four lead clinical trial drug candidates. The company has an exclusive partnership with Applied Pharmaceutical Innovation providing access to world-class, end-to-end … Continue reading “Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA)”
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |